Study to Evaluate the Safety and Tolerability of PRO-231 Ophthalmic Solution Versus VIGAMOXI ® on the Ocular Surface of Healthy Subjects.

Conditions: Ophthalmological Agent Toxicity Interventions: Drug: PRO-231; Drug: VIGAMOXI ® Sponsors: Laboratorios Sophia S.A de C.V. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials